Literature DB >> 30307745

Enhanced gastrointestinal passive paracellular permeability contributes to the obesity-associated hyperoxaluria.

Mohamed Bashir1, Jon Meddings2, Altayeb Alshaikh1, Daniel Jung1, Kim Le2, Ruhul Amin1, Sireesha Ratakonda1, Sapna Sharma1, Ignacio Granja3, Mustafa Satti1, John Asplin3, Hatim Hassan1.   

Abstract

Most kidney stones (KS) are composed of calcium oxalate and small increases in urine oxalate enhance the stone risk. Obesity is a risk factor for KS, and urinary oxalate excretion increases with increased body size. We previously established the obese ob/ob ( ob) mice as a model (3.3-fold higher urine oxalate) to define the pathogenesis of obesity-associated hyperoxaluria (OAH). The purpose of this study was to test the hypothesis that the obesity-associated enhanced small intestinal paracellular permeability contributes to OAH by increasing passive paracellular intestinal oxalate absorption. ob Mice have significantly higher jejunal (1.6-fold) and ileal (1.4-fold) paracellular oxalate absorption ex vivo and significantly higher (5-fold) urine [13C]oxalate following oral gavage with [13C]oxalate, indicating increased intestinal oxalate absorption in vivo. The observation of higher oxalate absorption in vivo compared with ex vivo suggests the possibility of increased paracellular permeability along the entire gut. Indeed, ob mice have significantly higher fractions of the administered sucrose (1.7-fold), lactulose (4.4-fold), and sucralose (3.1-fold) excreted in the urine, reflecting increased gastric, small intestinal, and colonic paracellular permeability, respectively. The ob mice have significantly reduced gastrointestinal occludin, zonula occludens-1, and claudins-1 and -3 mRNA and total protein expression. Proinflammatory cytokines and oxidative stress, which are elevated in obesity, significantly enhanced paracellular intestinal oxalate absorption in vitro and ex vivo. We conclude that obese mice have significantly higher intestinal oxalate absorption and enhanced gastrointestinal paracellular permeability in vivo, which would likely contribute to the pathogenesis of OAH, since there is a transepithelial oxalate concentration gradient to drive paracellular intestinal oxalate absorption. NEW & NOTEWORTHY This study shows that the obese ob/ob mice have significantly increased gastrointestinal paracellular oxalate absorption and remarkably enhanced paracellular permeability along the entire gut in vivo, which are likely mediated by the obesity-associated increased systemic and intestinal inflammation and oxidative stress. A transepithelial oxalate concentration gradient driving gastrointestinal paracellular oxalate absorption exists, and therefore, our novel findings likely contribute to the hyperoxaluria observed in the ob/ob mice and hence to the pathogenesis of obesity-associated hyperoxaluria.

Entities:  

Keywords:  gastrointestinal paracellular permeability; hyperoxaluria; inflammation; intestinal oxalate absorption; obesity; oxidative stress; tight junction proteins

Mesh:

Year:  2018        PMID: 30307745      PMCID: PMC6383380          DOI: 10.1152/ajpgi.00266.2018

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  68 in total

Review 1.  The roles and mechanisms of intestinal oxalate transport in oxalate homeostasis.

Authors:  Marguerite Hatch; Robert W Freel
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

2.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

3.  Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults.

Authors:  J Lemann; J A Pleuss; E M Worcester; L Hornick; D Schrab; R G Hoffmann
Journal:  Kidney Int       Date:  1996-01       Impact factor: 10.612

4.  Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis.

Authors:  Paola Brun; Ignazio Castagliuolo; Vincenza Di Leo; Andrea Buda; Massimo Pinzani; Giorgio Palù; Diego Martines
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-10-05       Impact factor: 4.052

Review 5.  Leaky gut and diabetes mellitus: what is the link?

Authors:  S de Kort; D Keszthelyi; A A M Masclee
Journal:  Obes Rev       Date:  2011-03-08       Impact factor: 9.213

6.  Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria.

Authors:  Ruhul Amin; John Asplin; Daniel Jung; Mohamed Bashir; Altayeb Alshaikh; Sireesha Ratakonda; Sapna Sharma; Sohee Jeon; Ignacio Granja; Dietrich Matern; Hatim Hassan
Journal:  Kidney Int       Date:  2018-02-01       Impact factor: 10.612

7.  Extracellular nucleotides inhibit oxalate transport by human intestinal Caco-2-BBe cells through PKC-δ activation.

Authors:  Ruhul Amin; Sapna Sharma; Sireesha Ratakonda; Hatim A Hassan
Journal:  Am J Physiol Cell Physiol       Date:  2013-04-17       Impact factor: 4.249

Review 8.  Glyoxylate synthesis, and its modulation and influence on oxalate synthesis.

Authors:  R P Holmes; D G Assimos
Journal:  J Urol       Date:  1998-11       Impact factor: 7.450

9.  24-h uric acid excretion and the risk of kidney stones.

Authors:  G C Curhan; E N Taylor
Journal:  Kidney Int       Date:  2007-12-05       Impact factor: 10.612

10.  Role of overweight status on stone-forming risk factors in children: a prospective study.

Authors:  Kemal Sarica; Bilal Eryildirim; Faruk Yencilek; Ugur Kuyumcuoglu
Journal:  Urology       Date:  2009-02-04       Impact factor: 2.649

View more
  2 in total

Review 1.  Urinary oxalate as a potential mediator of kidney disease in diabetes mellitus and obesity.

Authors:  Orhan Efe; Ashish Verma; Sushrut S Waikar
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-07       Impact factor: 2.894

2.  Role of insulin resistance and the gut microbiome on urine oxalate excretion in ob/ob mice.

Authors:  Hong Xiang; Haoqing Chen; Yuanyuan Liu; Dylan Dodd; Alan C Pao
Journal:  Physiol Rep       Date:  2022-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.